carbamazepine
PolandDrugs containing this active substance
-
It is used in the treatment of certain types of epilepsy, for the relief of pain occurring in some neurological diseases (e.g., trigeminal neuralgia), and in the prevention of bipolar mood disorders in individuals who do not respond to lithium treatment.
Form: tablets
Active substance Dosage carbamazepine 200 mg ATC: N03AF01
Manufacturer: Polpharma Pharmaceutical Works S.A.
-
This medicine is used to treat certain types of epilepsy, painful facial disease known as trigeminal neuralgia, and to control severe mood disorders when other medicines have not been effective.
Form: tablets, prolonged release
Active substance Dosage carbamazepine 200 mg ATC: N03AF01
Manufacturer: MIAS Pharma Limited Tillomed Malta Limited
-
The medicine is used to treat certain types of epilepsy, a painful facial condition called trigeminal neuralgia, and to control severe mood disorders when other medicines have not been effective.
Form: tablets, prolonged release
Active substance Dosage carbamazepine 400 mg ATC: N03AF01
Manufacturer: MIAS Pharma Limited Tillomed Malta Limited
-
The medicine is used in the treatment of epilepsy (various types of seizures), in cases of trigeminal or glossopharyngeal neuralgia, in diabetic neuropathic pain, and to prevent seizures in alcohol withdrawal syndrome (in hospital settings).
Form: tablets
Active substance Dosage carbamazepine 200 mg ATC: N03AF01
Manufacturer: Teva Operations Poland Sp. z o.o.
-
The medicine is used in the treatment of epilepsy (various types of seizures), in cases of trigeminal or glossopharyngeal neuralgia, in diabetic neuropathic pain, in multiple sclerosis, in the prophylaxis of bipolar affective disorder, and in the prevention of seizures in alcohol withdrawal syndrome.
Form: tablets, prolonged release
Active substance Dosage carbamazepine 200 mg ATC: N03AF01
Manufacturer: Teva Operations Poland Sp. z o.o.
-
The medicine is used in the treatment of epilepsy (various types of seizures), in cases of trigeminal or glossopharyngeal neuralgia, in diabetic neuropathy pain, in multiple sclerosis, and in the prophylaxis of bipolar affective disorders. It also helps to prevent seizures in alcohol withdrawal syndrome.
Form: tablets, prolonged release
Active substance Dosage carbamazepine 400 mg ATC: N03AF01
Manufacturer: Teva Operations Poland Sp. z o.o.
-
The medicine is used in the treatment of epilepsy (various types of seizures), manic syndromes, and in the prevention of bipolar disorder. It is also used in the treatment of alcohol withdrawal syndrome, diabetic neuropathy, and trigeminal neuralgia.
Form: tablets, prolonged release
Active substance Dosage carbamazepine 300 mg ATC: N03AF01
Manufacturer: Gerot Pharmazeutika GmbH
-
The medicinal product is used in the treatment of epilepsy (partial and generalized seizures), manic syndromes, and in the prevention of bipolar disorder. It is also used in alcohol withdrawal syndrome, in the treatment of trigeminal neuralgia (including in multiple sclerosis) and in diabetic neuropathy.
Form: tablets, prolonged release
Active substance Dosage carbamazepine 600 mg ATC: N03AF01
Manufacturer: Gerot Pharmazeutika GmbH
-
It is used in the treatment of epilepsy (various types of seizures), manic episodes, and in the prevention of relapses of bipolar disorder. It also helps in alcohol withdrawal syndrome and in the treatment of trigeminal neuralgia (including in multiple sclerosis) and glossopharyngeal neuralgia.
Form: suspension, oral
Active substance Dosage carbamazepine 20 mg ATC: N03AF01
Manufacturer: Novartis Farmaceutica S.A.
-
It is used in the treatment of epilepsy (various types of seizures), manic syndrome, and in the prevention of relapses of bipolar affective disorder. It also helps in the treatment of alcohol withdrawal syndrome and in cases of neuralgia (trigeminal or glossopharyngeal neuralgia).
Form: tablets, modified release
Active substance Dosage carbamazepine 200 mg ATC: N03AF01
Manufacturer: Novartis Farma S.p.A. Novartis Farmaceutica S.A.
-
The medicine is used in the treatment of epilepsy (partial and generalized seizures), manic episodes, and in the prevention of relapses of bipolar affective disorder. It is also used in alcohol withdrawal syndrome and in the treatment of trigeminal neuralgia (including in cases of multiple sclerosis) and glossopharyngeal neuralgia.
Form: tablets, modified release
Active substance Dosage carbamazepine 400 mg ATC: N03AF01
Manufacturer: Novartis Farma S.p.A. Novartis Farmaceutica S.A.